Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	4.08e-05	2	128	2	GO:0016639
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	4.08e-05	2	128	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	4.08e-05	2	128	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	4.08e-05	2	128	2	GO:0004354
GeneOntologyBiologicalProcess	neuron projection organization	TANC2 PPFIA2 CKAP5 AFDN TANC1 CTNND2 ABCD2	1.31e-05	127	126	7	GO:0106027
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	4.73e-05	2	129	2	PF02812
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	4.73e-05	2	129	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	4.73e-05	2	129	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	4.73e-05	2	129	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	4.73e-05	2	129	2	PF00208
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	4.73e-05	2	129	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	4.73e-05	2	129	2	PS00074
Domain	ELFV_dehydrog	GLUD1 GLUD2	4.73e-05	2	129	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	4.73e-05	2	129	2	IPR033524
Domain	PHD	ING5 BAZ1B JADE1 KMT2A SP140	1.70e-04	75	129	5	PF00628
Domain	Znf_PHD-finger	ING5 BAZ1B JADE1 KMT2A SP140	2.18e-04	79	129	5	IPR019787
Domain	PHD	ING5 BAZ1B JADE1 KMT2A SP140	3.80e-04	89	129	5	SM00249
Domain	Znf_PHD	ING5 BAZ1B JADE1 KMT2A SP140	4.21e-04	91	129	5	IPR001965
Domain	ZF_PHD_2	ING5 BAZ1B JADE1 KMT2A SP140	5.13e-04	95	129	5	PS50016
Domain	PAS_fold_3	KCNH3 PER2 AHR	5.15e-04	23	129	3	IPR013655
Domain	PAS_3	KCNH3 PER2 AHR	5.15e-04	23	129	3	PF08447
Domain	ZF_PHD_1	ING5 BAZ1B JADE1 KMT2A SP140	5.38e-04	96	129	5	PS01359
Domain	Znf_FYVE_PHD	ING5 BAZ1B JADE1 PIKFYVE KMT2A SP140	5.52e-04	147	129	6	IPR011011
Domain	PAS-assoc_C	KCNH3 PER2 AHR	5.86e-04	24	129	3	IPR000700
Domain	PAC	KCNH3 PER2 AHR	7.45e-04	26	129	3	IPR001610
Domain	PAC	KCNH3 PER2 AHR	7.45e-04	26	129	3	PS50113
Domain	PAC	KCNH3 PER2 AHR	7.45e-04	26	129	3	SM00086
Domain	Vinculin/catenin	TLN2 CTNNA2	9.72e-04	7	129	2	IPR006077
Domain	Zinc_finger_PHD-type_CS	ING5 BAZ1B JADE1 SP140	1.06e-03	65	129	4	IPR019786
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	H1-10 TMA16 DSG1 CKAP5 BAZ1B CAT ARHGAP11A NDUFA10 ITGB4 FAM83H KNOP1 ARG1 PARP1 SND1 UTP11 SURF6 GLUD1 PDCD11 AATF KIF2A SPEN HDLBP ATP5F1C	2.84e-10	1257	130	23	36526897
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	H1-10 ERP44 DSG1 MYCBP2 RBM10 CKAP5 BAZ1B CAT FAM83H ARG1 PARP1 SND1 GLUD1 PDCD11 AFDN AATF KIF2A SPEN HDLBP ATP5F1C	1.57e-09	1024	130	20	24711643
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TANC2 CAB39 IQGAP2 PPFIA2 AAK1 CKAP5 PARP1 SND1 GLUD1 GLUD2 KMT2A TLN2 AFDN KIF2A TANC1 CTNNA2 CTNND2 PLCH1 SIPA1L2 DCLK1 AGTPBP1 HDLBP ATP5F1C	3.39e-09	1431	130	23	37142655
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TANC2 MYCBP2 AAK1 CKAP5 FAM83H SLF2 RAB11FIP5 KMT2A AFDN AKAP11 KIF2A TANC1 PLCH1 CAMSAP1 SIPA1L2 DCLK1 BICC1 VCPIP1	3.91e-09	861	130	18	36931259
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	H1-10 MYCBP2 VPS13C CAT CPD CPOX CPT2 PIKFYVE PARP1 SND1 UTP11 SURF6 PTAR1 GLUD1 PDCD11 AATF AKAP11 TMEM131 KIF2A TANC1 MRRF VCPIP1 ATP5F1C	7.78e-09	1496	130	23	32877691
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TMA16 APTX AAK1 CKAP5 BAZ1B NDUFA10 ZHX2 KNOP1 SND1 SURF6 PDCD11 KMT2A AFDN AATF KIF2A TANC1 CTNNA2 CTNND2 ZBTB11 SPEN DCLK1 HDLBP ATP5F1C	7.88e-09	1497	130	23	31527615
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RANBP1 DSG1 RBM10 AAK1 CKAP5 BAZ1B SPART KNOP1 PARP1 SND1 SURF6 GLUD1 KMT2A PRR14L CAMSAP1 SIPA1L2 VCPIP1 HDLBP	1.37e-08	934	130	18	33916271
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	H1-10 TMA16 MCPH1 POLB RBM10 APTX ING5 CKAP5 BAZ1B ARHGAP11A KNOP1 DOCK5 PARP1 SLF2 SURF6 PDCD11 KMT2A AATF SPEN VCPIP1 ATP5F1C	1.51e-08	1294	130	21	30804502
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SOX4 TANC2 MYCBP2 JADE1 ITGB4 C2CD2 KCNH3 FAM83H TYK2 PIKFYVE PER2 SND1 SURF6 PDCD11 TLN2 TANC1 CAMSAP1 SIPA1L2 SPEN	3.20e-08	1105	130	19	35748872
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	H1-10 RANBP1 DSG1 MYCBP2 AAK1 CKAP5 BAZ1B CAT FAM83H ARG1 PARP1 NCAPG SND1 PDCD11 AFDN AATF PRR14L KIF2A TANC1 HDLBP ATP5F1C	3.23e-08	1353	130	21	29467282
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TANC2 DSG1 MYCBP2 PPFIA2 AAK1 CKAP5 NDUFA10 GLUD1 GLUD2 TLN2 AFDN KIF2A CTNNA2 CTNND2 CAMSAP1 SIPA1L2 DCLK1 VCPIP1 HDLBP	5.14e-08	1139	130	19	36417873
Pubmed	Association study of detoxification genes in age related macular degeneration.	CYP1A2 CAT PARP1 AHR	9.01e-08	12	130	4	15774926
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	H1-10 CCDC174 RBM10 BAZ1B NDUFA10 KNOP1 PARP1 SLF2 UTP11 SURF6 PDCD11 KMT2A AFDN AATF SPEN HDLBP ATP5F1C	1.09e-07	954	130	17	36373674
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	H1-10 MYCBP2 CKAP5 BAZ1B SND1 PREP SURF6 PDCD11 KMT2A AFDN AATF ZBTB11 SPEN HDLBP	1.74e-07	653	130	14	22586326
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	H1-10 RANBP1 ERP44 DSG1 VPS13C CKAP5 BAZ1B CPOX NDUFA10 PARP1 NCAPG SND1 GLUD1 PDCD11 TLN2 AFDN KIF2A SPEN HDLBP ATP5F1C	3.55e-07	1425	130	20	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RANBP1 IQGAP2 PPFIA2 HKDC1 CAT CPOX FER1L6 KNOP1 PARP1 SND1 DGAT2 GLUD1 GLUD2 KMT2A AATF PLCH1 SIPA1L2 ZBTB11 SPEN ATP5F1C	4.28e-07	1442	130	20	35575683
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	H1-10 DSG1 RBM10 BAZ1B KNOP1 ARG1 PARP1 SND1 PDCD11 KMT2A AATF SPEN ATP5F1C	4.80e-07	605	130	13	28977666
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RBM10 CKAP5 CPD RAB11FIP5 TMEM131 TANC1 CAMSAP1 SIPA1L2 VCPIP1	7.00e-07	263	130	9	34702444
Pubmed	Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry.	ETFDH CAT CPOX CPT2 NDUFA10 SND1 GLUD1 GLUD2 RAB11FIP5 ATP5F1C	7.14e-07	343	130	10	28130547
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MYCBP2 POLB CKAP5 SPART ARHGAP11A NCAPG GLUD2 KMT2A CAMSAP1 SPEN MRRF VCPIP1 ATP5F1C	9.80e-07	645	130	13	25281560
Pubmed	Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.	CYP1A2 ETFDH CPOX CPT2 NDUFA10 GLUD1 GLUD2 ATP5F1C	1.04e-06	203	130	8	16916647
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	H1-10 IQGAP2 MYCBP2 CKAP5 BAZ1B KNOP1 CEP78 SND1 SURF6 PDCD11 AATF KIF2A ZBTB11 AGTPBP1	1.05e-06	759	130	14	35915203
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RANBP1 MYCBP2 RBM10 BAZ1B NCAPG SND1 PDCD11 KMT2A AFDN SPEN VCPIP1 HDLBP	1.13e-06	549	130	12	38280479
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	H1-10 MYCBP2 RBM10 AAK1 CKAP5 BAZ1B ADARB1 KMT2A TLN2 AFDN SPEN AGTPBP1 VCPIP1 HDLBP	1.32e-06	774	130	14	15302935
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYCBP2 CKAP5 CHD9 NDUFA10 ADARB1 PARP1 SLF2 SURF6 HPF1 GLUD1 TLN2 AFDN TMEM131 CTNND2 ZBTB11 DCLK1 AGTPBP1 VCPIP1	1.49e-06	1285	130	18	35914814
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	H1-10 RANBP1 AAK1 CKAP5 FAM83H SND1 AFDN TANC1 CTNNA2 FAM110C VCPIP1 HDLBP	1.53e-06	565	130	12	25468996
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	AAK1 CKAP5 SPART CPD PARP1 SND1 RAB11FIP5 AFDN PLCH1 CAMSAP1 VCPIP1 HDLBP ATP5F1C	2.73e-06	708	130	13	39231216
Pubmed	A protein-RNA interaction atlas of the ribosome biogenesis factor AATF.	H1-10 RBM10 PARP1 SND1 PDCD11 AATF KIF2A	2.73e-06	162	130	7	31363146
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	H1-10 MYCBP2 BAZ1B SPART CPD PARP1 NCAPG SND1 SURF6 GLUD1 PDCD11 RAB11FIP5 AKAP11 TMEM131 TANC1 PLCH1 SIPA1L2 AGTPBP1 HDLBP	2.86e-06	1487	130	19	33957083
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RBM10 VPS8 CKAP5 ZHX2 PER2 PPIP5K1 SIPA1L2 SPEN AGTPBP1 VCPIP1	3.30e-06	407	130	10	12693553
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	DSG1 MYCBP2 AAK1 CKAP5 SPART CEP78 SND1 AATF TMEM131 CAMSAP1 SPEN AGTPBP1 HDLBP	3.48e-06	724	130	13	36232890
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	H1-10 RANBP1 IQGAP2 DSG1 RBM10 KNOP1 ARG1 PARP1 SND1 SURF6 PDCD11 TLN2 SPEN	3.86e-06	731	130	13	29298432
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ERP44 MYCBP2 CCDC174 VPS13C PIKFYVE SLC6A6 TMEM131 PRR14L TANC1 PLCH1 CAMSAP1 AGTPBP1 VCPIP1	3.98e-06	733	130	13	34672954
Pubmed	Glutamate dehydrogenase in cerebellar mutant mice: gene localization and enzyme activity in different tissues.	GLUD1 GLUD2 AGTPBP1	4.22e-06	9	130	3	2293612
Pubmed	Ethanol-induced conditioned taste aversion in BXD recombinant inbred mice.	PARP1 GLUD1 GLUD2	4.22e-06	9	130	3	9756038
Pubmed	Condensin I interacts with the PARP-1-XRCC1 complex and functions in DNA single-strand break repair.	POLB PARP1 NCAPG	4.22e-06	9	130	3	16543152
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	SPARC RBM10 ETFDH CAT CPOX CPT2 THUMPD2 TYK2 PARP1 SND1 GLUD1 RAB11FIP5 HDLBP ATP5F1C	4.38e-06	859	130	14	31536960
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TANC2 H1-10 ING5 BAZ1B CHD9 FAM83H KNOP1 TYK2 SULF2 SURF6 AHR RAB11FIP5 TANC1 SIPA1L2 AGTPBP1 SP140	4.49e-06	1116	130	16	31753913
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	TMA16 DSG1 RBM10 BAZ1B CAT ARHGAP11A PARP1 SND1 UTP11 PDCD11 AATF KIF2A ATP6V1C2 ZBTB11 ATP5F1C	4.67e-06	989	130	15	36424410
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	H1-10 DSG1 RBM10 BAZ1B CAT NDUFA10 ARG1 PARP1 NCAPG PDCD11 KIF2A ATP5F1C	5.54e-06	641	130	12	36057605
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	POLB BAZ1B CHD9 NDUFA10 CEP78 KMT2A AATF KIF2A PLCH1 ZBTB11 ATP5F1C	5.57e-06	533	130	11	30554943
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	CEMIP TYK2 DOCK5 SULF2 CEP78 KMT2A AFDN KIF2A TANC1 PLCH1 ZBTB11 ATP5F1C	6.37e-06	650	130	12	38777146
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	TANC2 MYCBP2 PPFIA2 AAK1 RAB11FIP5 CTNNA2 CTNND2 SIPA1L2 DCLK1	6.75e-06	347	130	9	17114649
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	TMA16 RBM10 AAK1 NDUFA10 SND1 GLUD1 KIF2A CAMSAP1 AGTPBP1 HDLBP ATP5F1C	7.10e-06	547	130	11	37267103
Pubmed	Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis.	CAT GLUD1 GLUD2	8.24e-06	11	130	3	11792727
Pubmed	Functional synergy of a human-specific and an ape-specific metabolic regulator in human neocortex development.	ARHGAP11A GLUD1 GLUD2	8.24e-06	11	130	3	38658571
Pubmed	Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis.	DSG1 ITGB4 CTNNA2	8.24e-06	11	130	3	21844209
Pubmed	Agrin has a pathological role in the progression of oral cancer.	RANBP1 IQGAP2 PARP1 SND1 AKAP11 TNNT3 HDLBP	9.87e-06	197	130	7	29872149
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	IQGAP2 PPFIA2 AAK1 TLN2 AKAP11 CTNNA2 CTNND2 DCLK1	1.14e-05	281	130	8	28706196
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	MYCBP2 CPD NDUFA10 PDCD11 KMT2A AFDN HDLBP	1.16e-05	202	130	7	24639526
Pubmed	Glutamate Delta-1 Receptor Regulates Inhibitory Neurotransmission in the Nucleus Accumbens Core and Anxiety-Like Behaviors.	GLUD1 GLUD2	1.39e-05	2	130	2	34173171
Pubmed	Glutamate dehydrogenase is essential to sustain neuronal oxidative energy metabolism during stimulation.	GLUD1 GLUD2	1.39e-05	2	130	2	28621566
Pubmed	In utero and lactational exposure to a complex mixture of polychlorinated biphenyls: toxicity in pups dependent on the Cyp1a2 and Ahr genotypes.	CYP1A2 AHR	1.39e-05	2	130	2	20961953
Pubmed	GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.	GLUD1 GLUD2	1.39e-05	2	130	2	32078638
Pubmed	Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.	GLUD1 GLUD2	1.39e-05	2	130	2	23595828
Pubmed	Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer.	IDO2 AHR	1.39e-05	2	130	2	37408267
Pubmed	Poly(ADP-ribosyl)ation affects stabilization of Che-1 protein in response to DNA damage.	PARP1 AATF	1.39e-05	2	130	2	21317046
Pubmed	Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways.	GLUD1 GLUD2	1.39e-05	2	130	2	21621574
Pubmed	Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.	GLUD1 GLUD2	1.39e-05	2	130	2	28911206
Pubmed	Delineation of glutamate pathways and secretory responses in pancreatic islets with β-cell-specific abrogation of the glutamate dehydrogenase.	GLUD1 GLUD2	1.39e-05	2	130	2	22875990
Pubmed	Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.	CYP1A2 AHR	1.39e-05	2	130	2	16538170
Pubmed	Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.	GLUD1 GLUD2	1.39e-05	2	130	2	15578726
Pubmed	Important role of Ser443 in different thermal stability of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	1.39e-05	2	130	2	15044002
Pubmed	Induction of excitatory and inhibitory presynaptic differentiation by GluD1.	GLUD1 GLUD2	1.39e-05	2	130	2	22138648
Pubmed	Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia.	GLUD1 GLUD2	1.39e-05	2	130	2	34220417
Pubmed	Expression of human GLUD1 and GLUD2 glutamate dehydrogenases in steroid producing tissues.	GLUD1 GLUD2	1.39e-05	2	130	2	26241911
Pubmed	Differential levels of glutamate dehydrogenase 1 (GLUD1) in Balb/c and C57BL/6 mice and the effects of overexpression of the Glud1 gene on glutamate release in striatum.	GLUD1 GLUD2	1.39e-05	2	130	2	21446915
Pubmed	Phenobarbital induces cytochrome P4501A2 hnRNA, mRNA and protein in the liver of C57BL/6J wild type and aryl hydrocarbon receptor knock-out mice.	CYP1A2 AHR	1.39e-05	2	130	2	9559668
Pubmed	GluD1 binds GABA and controls inhibitory plasticity.	GLUD1 GLUD2	1.39e-05	2	130	2	38060673
Pubmed	Gene expression patterns in the hippocampus during the development and aging of Glud1 (Glutamate Dehydrogenase 1) transgenic and wild type mice.	GLUD1 GLUD2	1.39e-05	2	130	2	24593767
Pubmed	Potentiation of neuronal activity by tonic GluD1 current in brain slices.	GLUD1 GLUD2	1.39e-05	2	130	2	37154294
Pubmed	Deletion of glutamate dehydrogenase 1 (Glud1) in the central nervous system affects glutamate handling without altering synaptic transmission.	GLUD1 GLUD2	1.39e-05	2	130	2	22924626
Pubmed	Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: implications for biologic function.	GLUD1 GLUD2	1.39e-05	2	130	2	11032875
Pubmed	HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.	PARP1 HPF1	1.39e-05	2	130	2	33683197
Pubmed	Loss of the aryl hydrocarbon receptor induces hypoxemia, endothelin-1, and systemic hypertension at modest altitude.	EDN1 AHR	1.39e-05	2	130	2	18212270
Pubmed	Localization of Human Glutamate Dehydrogenases Provides Insights into Their Metabolic Role and Their Involvement in Disease Processes.	GLUD1 GLUD2	1.39e-05	2	130	2	29943084
Pubmed	Glutamate dehydrogenase deficiency disrupts glutamate homeostasis in hippocampus and prefrontal cortex and impairs recognition memory.	GLUD1 GLUD2	1.39e-05	2	130	2	31898404
Pubmed	Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux.	GLUD1 GLUD2	1.39e-05	2	130	2	15378063
Pubmed	Ahrd Cyp1a2(-/-) mice show increased susceptibility to PCB-induced developmental neurotoxicity.	CYP1A2 AHR	1.39e-05	2	130	2	22935098
Pubmed	Widening Spectrum of Cellular and Subcellular Expression of Human GLUD1 and GLUD2 Glutamate Dehydrogenases Suggests Novel Functions.	GLUD1 GLUD2	1.39e-05	2	130	2	27422263
Pubmed	Poly(ADP-ribosyl)ation of Apoptosis Antagonizing Transcription Factor Involved in Hydroquinone-Induced DNA Damage Response.	PARP1 AATF	1.39e-05	2	130	2	26822515
Pubmed	DNA polymerase beta and PARP activities in base excision repair in living cells.	POLB PARP1	1.39e-05	2	130	2	19748837
Pubmed	Genetic differences in the aryl hydrocarbon receptor and CYP1A2 affect sensitivity to developmental polychlorinated biphenyl exposure in mice: relevance to studies of human neurological disorders.	CYP1A2 AHR	1.39e-05	2	130	2	29197979
Pubmed	Critical role of the cysteine 323 residue in the catalytic activity of human glutamate dehydrogenase isozymes.	GLUD1 GLUD2	1.39e-05	2	130	2	15750346
Pubmed	HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.	PARP1 HPF1	1.39e-05	2	130	2	33589610
Pubmed	Integrin β4 regulates SPARC protein to promote invasion.	SPARC ITGB4	1.39e-05	2	130	2	22308039
Pubmed	Molecular cloning, structure and expression analysis of a full-length mouse brain glutamate dehydrogenase cDNA.	GLUD1 GLUD2	1.39e-05	2	130	2	1711373
Pubmed	Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.	GLUD1 GLUD2	1.39e-05	2	130	2	20529287
Pubmed	Determination of glutamate dehydrogenase activity and its kinetics in mouse tissues using metabolic mapping (quantitative enzyme histochemistry).	GLUD1 GLUD2	1.39e-05	2	130	2	25124006
Pubmed	A Cyp1a2-luciferase transgenic CD-1 mouse model: responses to aryl hydrocarbons similar to the humanized AhR mice.	CYP1A2 AHR	1.39e-05	2	130	2	15329440
Pubmed	Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase.	GLUD1 GLUD2	1.39e-05	2	130	2	23673664
Pubmed	Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.	EDN1 PARP1	1.39e-05	2	130	2	18516100
Pubmed	Lack of evidence for direct ligand-gated ion channel activity of GluD receptors.	GLUD1 GLUD2	1.39e-05	2	130	2	39052831
Pubmed	Metabolism changes during aging in the hippocampus and striatum of glud1 (glutamate dehydrogenase 1) transgenic mice.	GLUD1 GLUD2	1.39e-05	2	130	2	24442550
Pubmed	The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity.	GLUD1 GLUD2	1.39e-05	2	130	2	27137930
Pubmed	GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution.	GLUD1 GLUD2	1.39e-05	2	130	2	26440896
Pubmed	Study of structure-function relationships in human glutamate dehydrogenases reveals novel molecular mechanisms for the regulation of the nerve tissue-specific (GLUD2) isoenzyme.	GLUD1 GLUD2	1.39e-05	2	130	2	12742085
Pubmed	Blockade of SOX4 mediated DNA repair by SPARC enhances radioresponse in medulloblastoma.	SOX4 SPARC	1.39e-05	2	130	2	22542805
Pubmed	Mitochondrial targeting adaptation of the hominoid-specific glutamate dehydrogenase driven by positive Darwinian selection.	GLUD1 GLUD2	1.39e-05	2	130	2	18688271
Pubmed	The complex regulation of human glud1 and glud2 glutamate dehydrogenases and its implications in nerve tissue biology.	GLUD1 GLUD2	1.39e-05	2	130	2	22658952
Interaction	AATF interactions	H1-10 MYCBP2 RBM10 CPD ADARB1 PARP1 SND1 UTP11 SURF6 PDCD11 AATF KIF2A HDLBP	9.03e-07	376	129	13	int:AATF
Interaction	YWHAZ interactions	TANC2 SPARC ERP44 MYCBP2 PPFIA2 AAK1 CKAP5 CAT ZHX2 FAM83H ARG1 PER2 B3GNT2 RAB11FIP5 KMT2A AFDN AKAP11 PRR14L KIF2A TANC1 PLCH1 CAMSAP1 SIPA1L2 DCLK1	2.96e-06	1319	129	24	int:YWHAZ
Interaction	ZYX interactions	TANC2 IQGAP2 AAK1 SPART NUBP1 TLN2 AKAP11 TANC1 CAMSAP1 SIPA1L2 HDLBP	8.91e-06	329	129	11	int:ZYX
Interaction	NUP43 interactions	H1-10 RANBP1 DSG1 CHD9 ZHX2 KNOP1 SND1 SLF2 SURF6 PDCD11 KMT2A AATF KIF2A ZBTB11 SPEN	1.14e-05	625	129	15	int:NUP43
Interaction	TRIM52 interactions	IQGAP2 FAM83H UTP11 AHR PRR14L TANC1 SIPA1L2	2.38e-05	133	129	7	int:TRIM52
Interaction	KCTD13 interactions	TANC2 CAB39 LAMB4 IQGAP2 PPFIA2 AAK1 CKAP5 PARP1 SND1 GLUD1 KMT2A TLN2 AFDN KIF2A TANC1 CTNNA2 CTNND2 PLCH1 SIPA1L2 DCLK1 AGTPBP1 HDLBP ATP5F1C	2.39e-05	1394	129	23	int:KCTD13
Interaction	H2BC9 interactions	H1-10 DSG1 ING5 CKAP5 BAZ1B HKDC1 ADARB1 EGFL6 PARP1 SULF2 AKAP11 ZBTB11	3.01e-05	446	129	12	int:H2BC9
Interaction	KCNA3 interactions	AAK1 CKAP5 SPART CHD9 CPD PARP1 SND1 RAB11FIP5 KMT2A TLN2 AFDN PLCH1 CAMSAP1 SPEN VCPIP1 HDLBP ATP5F1C	4.12e-05	871	129	17	int:KCNA3
Interaction	NAA40 interactions	RANBP1 DSG1 RBM10 AAK1 CKAP5 BAZ1B SPART KNOP1 PARP1 SND1 SURF6 GLUD1 KMT2A PRR14L CAMSAP1 SIPA1L2 VCPIP1 HDLBP	5.16e-05	978	129	18	int:NAA40
Interaction	DYRK1A interactions	H1-10 MYCBP2 RBM10 CKAP5 TNS2 CAT ITGB4 RAB11FIP5 AKAP11 TANC1 CAMSAP1 SIPA1L2 ZBTB11	5.50e-05	552	129	13	int:DYRK1A
Interaction	HECTD1 interactions	H1-10 IQGAP2 MYCBP2 CKAP5 BAZ1B KNOP1 PARP1 NCAPG CEP78 SND1 SURF6 PDCD11 AATF KIF2A ATP6V1C2 ZBTB11 AGTPBP1 ATP5F1C	5.58e-05	984	129	18	int:HECTD1
Interaction	HMGN5 interactions	H1-10 POLB ING5 BAZ1B PARP1 GLUD1 KMT2A	6.09e-05	154	129	7	int:HMGN5
Interaction	YWHAH interactions	TANC2 MYCBP2 AAK1 CKAP5 TNS2 FAM83H SLF2 RAB11FIP5 KMT2A AFDN AKAP11 KIF2A TANC1 PLCH1 CAMSAP1 SIPA1L2 DCLK1 BICC1 VCPIP1	7.52e-05	1102	129	19	int:YWHAH
Interaction	HMGA1 interactions	H1-10 POLB ING5 BAZ1B TYK2 PARP1 PER2 HPF1 KMT2A CAMSAP1 SPEN	8.14e-05	419	129	11	int:HMGA1
Interaction	POLR1E interactions	IQGAP2 KNOP1 PARP1 UTP11 PDCD11 KMT2A AATF ZBTB11 AGTPBP1 ATP5F1C	8.67e-05	350	129	10	int:POLR1E
Interaction	SCARNA22 interactions	RBM10 BAZ1B PARP1 PDCD11 AATF HDLBP	1.12e-04	118	129	6	int:SCARNA22
Interaction	YWHAG interactions	TANC2 SPARC MYCBP2 AAK1 CKAP5 TNS2 FAM83H CEP78 RAB11FIP5 KMT2A PPIP5K1 AFDN AKAP11 KIF2A TANC1 PLCH1 CAMSAP1 SIPA1L2 DCLK1 BICC1	1.30e-04	1248	129	20	int:YWHAG
Interaction	RBM28 interactions	ADARB1 KNOP1 PARP1 UTP11 SURF6 FBXO43 PDCD11 AATF MRRF HDLBP	1.31e-04	368	129	10	int:RBM28
Interaction	SFN interactions	TANC2 MYCBP2 AAK1 JADE1 ARHGAP11A FAM83H KMT2A AKAP11 KIF2A TANC1 PLCH1 CAMSAP1 SIPA1L2 VCPIP1	1.42e-04	692	129	14	int:SFN
Cytoband	Ensembl 112 genes in cytogenetic band chr2q37	CAB39 ING5 NDUFA10 PER2 HDLBP SP140	4.78e-05	226	130	6	chr2q37
Cytoband	2q37.3	ING5 NDUFA10 PER2 HDLBP	7.08e-05	77	130	4	2q37.3
GeneFamily	PHD finger proteins	ING5 BAZ1B JADE1 KMT2A SP140	3.58e-05	90	75	5	88
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MYCBP2 CKAP5 BAZ1B SPART CHD9 ARHGAP11A ZHX2 ADARB1 C2CD2 CEMIP PIKFYVE AKAP11 TMEM131 KIF2A ZBTB11 SPEN	5.49e-06	856	130	16	M4500
Coexpression	GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN	TANC2 CPOX KNOP1 SND1 DGAT2 B3GNT2 HPF1 PTAR1	7.06e-06	199	130	8	M6098
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	MYCBP2 CKAP5 CHD9 ZHX2 ADARB1 C2CD2 CEMIP PIKFYVE TMEM131 KIF2A SPEN	2.17e-05	466	130	11	M13522
Coexpression	GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN	IQGAP2 AAK1 NUBP1 CPD ADARB1 UTP11 ATP6V1C2	3.96e-05	185	130	7	M7567
Coexpression	CHEBOTAEV_GR_TARGETS_UP	IQGAP2 CHD9 DOCK5 SULF2 RAB11FIP5	4.12e-05	77	130	5	M4263
Coexpression	CHEBOTAEV_GR_TARGETS_UP	IQGAP2 CHD9 DOCK5 SULF2 RAB11FIP5	4.67e-05	79	130	5	MM469
Coexpression	GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN	RANBP1 TMA16 MCPH1 ETFDH PARP1 PREP GLUD1	6.29e-05	199	130	7	M5284
Coexpression	GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP	TMEM176B MYCBP2 CHD9 EDN1 SULF2 PREP B3GNT2	6.49e-05	200	130	7	M6186
Coexpression	HALLMARK_XENOBIOTIC_METABOLISM	CYP1A2 TMEM176B ETFDH CAT ARG1 SLC6A6 ABCD2	6.49e-05	200	130	7	M5934
Coexpression	GSE3982_DC_VS_NEUTROPHIL_UP	SOX4 SPARC TMA16 ETFDH CPT2 UTP11 GLUD1	6.49e-05	200	130	7	M5461
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SOX4 SPARC VPS13C SLITRK4 VPS8 CHD9 JADE1 EDN1 KMT2A AFDN	3.84e-10	199	130	10	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX4 SPARC MYCBP2 CPD JADE1 SLC6A6 AHR AFDN	9.13e-08	190	130	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	BAL-Control-cDC_6\|Control / Compartment, Disease Groups and Clusters	SLITRK4 THUMPD2 CEMIP TLN2 DSEL PPP1R36 HDLBP	6.41e-07	168	130	7	65ec473cff748b334c0a66e33bc34a8465fe7631
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 MYCBP2 VPS13C BAZ1B CHD9 SLF2 KMT2A	1.18e-06	184	130	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SOX4 H1-10 LAMB4 VPS13C PPFIA2 AHR AGTPBP1	1.27e-06	186	130	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	SOX4 CAT DOCK5 AHR TANC1 CTNND2 BICC1	1.57e-06	192	130	7	e16035b3328f9b1b2e28d234c62ba88387540550
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 CKAP5 BAZ1B CHD9 EGFL6 PARP1 PREP	1.68e-06	194	130	7	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 LAMB4 NKX6-2 PPFIA2 FBXO43 CTNNA2	8.19e-06	162	130	6	373513f9d0e5007b2e10a8b78d4909dcce9e3b62
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	TMEM176B IQGAP2 ITGB4 DOCK5 CTNND2 SIPA1L2	1.19e-05	173	130	6	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 TMEM176B ITGB4 AHR TMEM131 PLCH1	1.23e-05	174	130	6	0fccd90ef72ec2e5eb369fe6d6d126c60886485a
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	H1-10 APTX PSPH SULF2 AFDN CTNND2	1.27e-05	175	130	6	e99e145a152f534b75267ec492a252a0b814b4f8
ToppCell	droplet-Marrow-BM-1m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 SPARC CAT EGFL6 SULF2 PREP	1.69e-05	184	130	6	69348c9237e44f7752ac01f60e733ad41580fdb8
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 WAS MYCBP2 VPS13C CHD9 PARP1	1.74e-05	185	130	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	(00)_Basal-(4)_1wkpi\|(00)_Basal / shred by cell type and Timepoint	SPARC TNS2 ITGB4 SLC6A6 PER2 ATP6V1C2	1.74e-05	185	130	6	bf82ba905e5eee1c39a2731702071d3de10a78b8
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 SPARC BAZ1B ARHGAP11A EDN1 PARP1	1.80e-05	186	130	6	15ab6666748a641226e42e6ca6eeaf186a501c95
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITGB4 EDN1 SLC6A6 SULF2 TLN2 DCLK1	1.80e-05	186	130	6	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 SPARC BAZ1B ARHGAP11A EDN1 PARP1	1.80e-05	186	130	6	4ed1b97e2552f3c4134f25665d7513498ffac16c
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SOX4 IQGAP2 AAK1 DOCK5 AHR TANC1	1.80e-05	186	130	6	855c2e5a8a6cf94c7de31982e0e2416f924439d3
ToppCell	droplet-Tongue-nan-24m-Epithelial-basal_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 SPARC TMEM176B ITGB4 SLC6A6 FAM110C	1.85e-05	187	130	6	13056622d9921ee0b03325701d94df82ffbaa5d4
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 CPD ZHX2 DNAH14 SULF2 BICC1	1.91e-05	188	130	6	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	ITGA10 CPD ITGB4 EDN1 SULF2 KCNT2	2.15e-05	192	130	6	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	MCPH1 CKAP5 CEMIP SLC6A6 PREP KIF2A	2.21e-05	193	130	6	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-basal_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 TANC2 SPARC TMEM176B ITGB4 SLC6A6	2.34e-05	195	130	6	eaadc79f53b1cb208c6f7999925f318e1378197f
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	SPARC ADARB1 CEMIP KCNT2 DCLK1 BICC1	2.48e-05	197	130	6	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	TANC2 MYCBP2 VPS13C AAK1 KIF2A HDLBP	2.55e-05	198	130	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	TANC2 CEBPE CKAP5 ARG1 B3GNT2 HDLBP	2.70e-05	200	130	6	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	SOX4 MYCBP2 SLITRK4 AFDN KIF2A AGTPBP1	2.70e-05	200	130	6	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	H1-10 IQGAP2 MYCBP2 VPS13C KMT2A KIF2A	2.70e-05	200	130	6	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Severe-B_intermediate-1\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CYP1A2 SPART NBPF11 PIKFYVE AFDN	3.44e-05	126	130	5	42a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMB4 DSG1 PPFIA2 PLCH1 FAM110C	4.30e-05	132	130	5	182973660929fe4174e0354c85863a25518c18c1
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8\|TCGA-Thymus / Sample_Type by Project: Shred V9	PPFIA2 EGFL6 KCNT2 DCLK1 BICC1	8.14e-05	151	130	5	5906562efd36fbcb91f96e0a0d3a8fe999ba1e79
ToppCell	Control-Myeloid-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEBPE DOCK5 IDO2 SULF2 DGAT2	8.66e-05	153	130	5	c33d63b2d1a220bc428e776b157b23faa43ea8ca
ToppCell	Control-Myeloid-Neutrophils-Neutrophils\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEBPE DOCK5 IDO2 SULF2 DGAT2	8.66e-05	153	130	5	e3630f2b10f33092a3b6a63dba3a39fbdecbc7bd
ToppCell	facs-Lung-EPCAM-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 EDN1 B3GNT2 HPF1 TSKS	9.21e-05	155	130	5	0e942609d3e060f1e589fee5997fc6299f3d18bc
ToppCell	facs-Lung-EPCAM-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKX6-2 EDN1 B3GNT2 HPF1 TSKS	9.49e-05	156	130	5	bb64bf520cb74897a01c64924a85a1550df2b801
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epi_progenitor\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TANC2 PPFIA2 EGFL6 FAM83H TNNT3	1.04e-04	159	130	5	a4bfd59c53237964fc24a24de5c1925fdd01db99
ToppCell	droplet-Fat-SCAT-30m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 TMEM176B SULF2 RAB11FIP5 TNNT3	1.07e-04	160	130	5	61eefe84c8e30d8a3812f5b48d26ed01739aa1ce
ToppCell	normal_Pleural_Fluid-T/NK_cells-CD4+_Th\|T/NK_cells / Location, Cell class and cell subclass	ANKRD13B CAB39 CEBPE AMZ2 FAM110C	1.20e-04	164	130	5	334f376350c9cf92611d0f75b2e18a102f4c116a
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	TMEM176B IQGAP2 ITGB4 DOCK5 AHR	1.23e-04	165	130	5	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	CV-Mild-3\|Mild / Virus stimulation, Condition and Cluster	SOX4 CABLES2 EGFL6 RAB11FIP5 ATP6V1C2	1.27e-04	166	130	5	5599f90fc0e15a3670b03187085eba91228390a2
ToppCell	Basal_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD13B ITGB4 CEMIP TNNT3 FAM110C	1.27e-04	166	130	5	aea2ae12e4746149ebc6da063ef694381c098f80
ToppCell	Control-B_intermediate-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SPART NBPF11 SLF2 HPF1 AFDN	1.31e-04	167	130	5	948504367ecf58144d9dd74d2ec531358fc4b309
ToppCell	droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADARB1 PER2 DGAT2 AHR MRRF	1.34e-04	168	130	5	2201ae834b53cbdc085f8f02607fa5b5bd911268
ToppCell	facs-Tongue-nan-3m-Epithelial-basal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EDN1 ADGB TNNT3 FAM110C DCLK1	1.34e-04	168	130	5	ca0c4a819f9047fc40d224f7656fec60f6fa05d8
ToppCell	droplet-Fat-Bat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMA16 CEBPE IQGAP2 VPS13C PRR14L	1.34e-04	168	130	5	6fddc957a0503455d8c165862b5eb8e5fdb8a510
ToppCell	droplet-Fat-Bat-18m-Myeloid-myeloid_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMA16 CEBPE IQGAP2 VPS13C PRR14L	1.34e-04	168	130	5	794035cb63353a7d02fd9939deb5b4d075c9d95a
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HKDC1 EGFL6 PPIP5K1 PRR14L VCPIP1	1.34e-04	168	130	5	08f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCell	droplet-Fat-Bat-18m-Myeloid\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMA16 CEBPE IQGAP2 VPS13C PRR14L	1.34e-04	168	130	5	1e23b634f96e88b976a523ca1f3fc08f6fe9b239
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMA16 CEBPE MCPH1 DGAT2 TANC1	1.46e-04	171	130	5	fea6ef6bbfebea2dd0f0360c7db7a5e858f15958
ToppCell	normal-na-Lymphocytic_T-T4_em-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	AAK1 ARHGAP11A EGFL6 AFDN KIF2A	1.46e-04	171	130	5	61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMA16 CEBPE MCPH1 DGAT2 TANC1	1.46e-04	171	130	5	f15594fd4d709920733de9376a391dedc62b65de
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AFDN PLCH1 HBE1 FAM110C	1.46e-04	91	130	4	b0658e020f80e56fab9d2aa07e321d9b33d7af2c
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEIKIN CAT CPOX ARG1 HBE1	1.50e-04	172	130	5	cc1a45a35f78063b2a777ae905f70f894fbcb22f
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEIKIN CAT CPOX ARG1 HBE1	1.50e-04	172	130	5	30c57f5ca2326e8d890d9aac8096c64e5b51a24f
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEIKIN CAT CPOX ARG1 HBE1	1.58e-04	174	130	5	001254db9f4c346d06d31a7fa1213498f92e4280
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CEMIP KCNT2 TANC1 CTNND2 BICC1	1.58e-04	174	130	5	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARHGAP11A DOCK5 NCAPG SULF2 ABCD2	1.58e-04	174	130	5	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 TMEM176B ITGB4 AHR TMEM131	1.58e-04	174	130	5	b2fc2a756f8e373ad903bd416d9de703d945fa1c
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEIKIN CAT CPOX ARG1 HBE1	1.58e-04	174	130	5	ce2bc1797707c3f48ef551de7edbfd7b47e5a36e
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 CAT PREP B3GNT2 TMEM131	1.67e-04	176	130	5	29cda51a99100ddd2928cadc92da40f001d7e1f4
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	SPARC ZHX2 KCNT2 DCLK1 BICC1	1.67e-04	176	130	5	08f94b78b27feeb113dbfadbfa7fe34d08b2809b
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C CKAP5 CHD9 KCNT2 HDLBP	1.67e-04	176	130	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX4 CAT PREP B3GNT2 TMEM131	1.67e-04	176	130	5	01774a86d7d92f31a056b753f9844f923038003e
ToppCell	RV-11._Adipocyte\|World / Chamber and Cluster_Paper	C2CD2 DGAT2 PPIP5K1 TLN2 ABCD2	1.71e-04	177	130	5	f0edf04930692418953e4f00a917257804ec0ffd
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CEMIP IDO2 SULF2 TANC1 PPP1R36	1.71e-04	177	130	5	3a150dcaefa342d49968b42c7cdb1fbb633adcd0
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CEMIP IDO2 SULF2 TANC1 PPP1R36	1.71e-04	177	130	5	c9e5820ff0bc7ad1adcfb2651713fdfc58bced56
ToppCell	Endothelial-Endothelial-C\|Endothelial / shred on cell class and cell subclass (v4)	SOX4 CABLES2 PPFIA2 EDN1 SLC6A6	1.71e-04	177	130	5	b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	H1-10 CKAP5 ARHGAP11A EGFL6 NCAPG	1.71e-04	177	130	5	3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	CPD CEMIP DGAT2 SURF6 GLUD2	1.71e-04	177	130	5	eb0cfe8e9a91910f9979608ed47add48d98ce4dd
ToppCell	RV-11._Adipocyte\|RV / Chamber and Cluster_Paper	MYCBP2 C2CD2 DGAT2 PPIP5K1 ABCD2	1.76e-04	178	130	5	278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	CEMIP DGAT2 SURF6 GLUD2 CAMSAP1	1.76e-04	178	130	5	536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIA2 MEIKIN ARG1 GLUD1 DCLK1	1.81e-04	179	130	5	7c8a2fa1326c73dc9e774df645b572864fd97133
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SOX4 TANC2 FER1L6 PER2 TANC1	1.81e-04	179	130	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	RA-16._Neuronal\|World / Chamber and Cluster_Paper	TMEM176B IQGAP2 ITGB4 DOCK5 AHR	1.90e-04	181	130	5	7d22a43f887e0747f0cb87ba364ff27905ee6eec
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA10 F8 PTAR1 AFDN ZBTB11	1.90e-04	181	130	5	e2d03115a87f45a7ddd3ade6b9ac3843639bd41a
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIA2 CPD ADARB1 F8 TANC1	1.90e-04	181	130	5	a53f05c4c47465ee62e353716456bd09ab464b23
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA10 F8 PTAR1 AFDN ZBTB11	1.90e-04	181	130	5	d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264
ToppCell	droplet-Marrow-BM-1m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPARC CAT EGFL6 SULF2 PREP	1.90e-04	181	130	5	89c551de26de047c316c91ac1d97bdf728a33d9e
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEIKIN CAT CPOX ARG1 HBE1	1.90e-04	181	130	5	f4cd6dba4c04c5cb550f44468eb29c07238fbda4
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEIKIN CAT CPOX ARG1 HBE1	1.90e-04	181	130	5	c7f5d0e5aa2ca6a409957713637e1b37a73ceb60
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 LAMB4 NKX6-2 PPFIA2 FAM110C	1.95e-04	182	130	5	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	(00)_Basal-(0)_uninjured\|(00)_Basal / shred by cell type and Timepoint	SPARC TMEM176B TNS2 SLC6A6 ATP6V1C2	1.95e-04	182	130	5	c02c9cab4389d80f318f4bb8d703c1e719672624
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SOX4 IQGAP2 AAK1 DOCK5 TANC1	1.95e-04	182	130	5	b86690c109cdc16844a6cd2216c1bf2bf28efd45
ToppCell	Basal\|World / shred by cell class for mouse tongue	SOX4 SPARC ADARB1 ITGB4 SLC6A6	2.00e-04	183	130	5	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	ITGB4 FER1L6 CEMIP SULF2 SIPA1L2	2.00e-04	183	130	5	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 ADARB1 SLC6A6 SULF2 ABCD2	2.00e-04	183	130	5	ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TANC2 CEBPE SPART ARG1 HDLBP	2.05e-04	184	130	5	a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TANC2 CEBPE SPART ARG1 HDLBP	2.05e-04	184	130	5	081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCell	Control-Myeloid_G-immature_Neutrophil\|Control / Disease group, lineage and cell class	TANC2 CEBPE SPART ARG1 HDLBP	2.05e-04	184	130	5	45f873236f7e90fb78c8e291d3b5b92d121acec9
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TANC2 CEBPE SPART ARG1 HDLBP	2.05e-04	184	130	5	84c20730cd92b9aaa50077d7b625e37e7f9e91d2
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 LAMB4 PPFIA2 HKDC1 KCNH3	2.05e-04	184	130	5	d33de57876817050b294f2ecb0a4eb0634cfa7f0
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	WAS CPD ARG1 DGAT2 CTNND2	2.05e-04	184	130	5	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TANC2 CEBPE SPART ARG1 HDLBP	2.05e-04	184	130	5	d31d4116d1d196633784863781fa45673607a421
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CKAP5 ARHGAP11A PARP1 NCAPG SP140	2.05e-04	184	130	5	8f40093de5bb978f046d66e8f05f333686a009a4
ToppCell	droplet-Lung-nan-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 ADARB1 SLC6A6 SULF2 ABCD2	2.05e-04	184	130	5	3261d767d5e3d9e9fbac22ad73ca14e44beed89c
ToppCell	10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MEIKIN CAT CPOX ARG1 HBE1	2.10e-04	185	130	5	e9059cefcdf0972ec90793b1dd34c3292b17a061
ToppCell	Mild-CD4+_T\|Mild / Disease group and Cell class	SPART TNS2 AHR RAB11FIP5 AFDN	2.10e-04	185	130	5	c28ecb63146de1b02418e5a4fad0ae7c2b66a41d
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	CEMIP KCNT2 TLN2 DCLK1 BICC1	2.10e-04	185	130	5	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	CF-Lymphoid-pDC\|Lymphoid / Disease state, Lineage and Cell class	SOX4 H1-10 POLB SPART SULF2	2.21e-04	187	130	5	adc79e5804ab98006dbdf1d76ef0d8f85cc5cb0f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 CPD ZHX2 DNAH14 BICC1	2.21e-04	187	130	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
Drug	5186223; Up 200; 12uM; MCF7; HT_HG-U133A_EA	ERP44 MCPH1 BAZ1B SPART CHD9 CPD ITGB4 SLC6A6 KIF2A CTNND2	2.33e-07	200	130	10	885_UP
Drug	3-aminopicolinate	APTX GLUD1 GLUD2	1.80e-06	5	130	3	CID000073836
Drug	Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; MCF7; HT_HG-U133A	TMA16 SPART PSPH F8 SND1 RAB11FIP5 TLN2 PLCH1 TSKS	2.11e-06	198	130	9	5992_DN
Drug	Tea	CYP1A2 POLB CAT PARP1 AHR	2.42e-06	38	130	5	ctd:D013662
Drug	Glu-P-2	CYP1A2 PARP1 AHR	3.59e-06	6	130	3	ctd:C023847
Drug	isodiazinon	CPOX GLUD1 GLUD2	3.59e-06	6	130	3	CID000133913
Drug	2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole	CYP1A2 PARP1 AHR	6.26e-06	7	130	3	ctd:C023785
Drug	Nessler's reagent	ARG1 GLUD1 GLUD2	9.98e-06	8	130	3	CID000024542
Drug	AC1MQ2IK	CAT GLUD1 GLUD2	9.98e-06	8	130	3	CID003394958
Drug	Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; HL60; HT_HG-U133A	WAS PSPH ADGB SLF2 TLN2 KIF2A CAMSAP1 VCPIP1	1.55e-05	193	130	8	1341_UP
Drug	2-amino-9H-pyrido(2,3-b)indole	CYP1A2 PARP1 AHR	2.12e-05	10	130	3	ctd:C017822
Drug	myristicin	CYP1A2 AHR SPEN	2.12e-05	10	130	3	CID000004276
Drug	diglycerol	DGAT2 GLUD1 GLUD2	2.12e-05	10	130	3	CID000042953
Drug	2,3,7,8-tetrabromodibenzo-4-dioxin	CYP1A2 CAT ARG1 GLUD1 AHR	2.20e-05	59	130	5	ctd:C066841
Drug	2-amino-3-methyl-9H-pyrido(2,3-b)indole	CYP1A2 PARP1 AHR	2.90e-05	11	130	3	ctd:C017821
Drug	6-methyl-1,3,8-trichlorodibenzofuran	SOX4 CYP1A2 AHR	2.90e-05	11	130	3	ctd:C054923
Drug	sulfoacetic acid	CAT GLUD1 GLUD2	2.90e-05	11	130	3	CID000031257
Drug	phenyltriethoxysilane	GLUD1 GLUD2	3.24e-05	2	130	2	CID000013075
Drug	2-methylnaphthalene	CYP1A2 AHR	3.24e-05	2	130	2	ctd:C027384
Drug	2,3,4,5,6-pentabromotoluene	CAT AHR	3.24e-05	2	130	2	ctd:C053745
Drug	G-3SH	GLUD1 GLUD2	3.24e-05	2	130	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	3.24e-05	2	130	2	CID006455327
Drug	methylmercuric bromide	GLUD1 GLUD2	3.24e-05	2	130	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	3.24e-05	2	130	2	CID000068137
Drug	x 1 s	GLUD1 GLUD2	3.24e-05	2	130	2	CID000409694
Drug	2-amino-4-hydroxymethyl-3,8-dimethylimidazo(4,5-f)quinoxaline	CYP1A2 AHR	3.24e-05	2	130	2	ctd:C085470
Drug	1-methylnaphthalene	CYP1A2 AHR	3.24e-05	2	130	2	ctd:C025968
Drug	AC1L193Y	CAT CPT2 ACOT12 GLUD1 GLUD2	3.53e-05	65	130	5	CID000000380
Drug	3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole	CYP1A2 PARP1 AHR	3.85e-05	12	130	3	ctd:C019132
Drug	n-propionyl-CoA	ETFDH CPT2 ACOT12 DGAT2 GLUD1 GLUD2 ABCD2	4.81e-05	166	130	7	CID000001033
Drug	5-hydroxythiabendazole	CYP1A2 GLUD1 GLUD2	4.99e-05	13	130	3	CID000108227
Drug	sporidesmin	NKX6-2 GLUD1 GLUD2	4.99e-05	13	130	3	CID000099596
Drug	phylloerythrin	ARG1 GLUD1 GLUD2	4.99e-05	13	130	3	CID005480977
Drug	Skatole	CYP1A2 PARP1 AHR	4.99e-05	13	130	3	ctd:D012862
Drug	ciprofibrate	CYP1A2 TMEM176B CKAP5 CHD9 CAT CPT2 AHR	5.59e-05	170	130	7	CID000002763
Drug	isoliquiritigenin	CYP1A2 CAT ARG1 PARP1 AHR	6.18e-05	73	130	5	ctd:C040920
Drug	Ubiquinone	ETFDH CAT PARP1	6.32e-05	14	130	3	ctd:D014451
Drug	coproporphyrinogen III	CYP1A2 CAT CPOX AHR	6.44e-05	38	130	4	CID000000321
Drug	potassium phosphate	CYP1A2 POLB CAT ACOT12 GLUD1 GLUD2	6.93e-05	121	130	6	CID000024450
Drug	BCMTD	CAT CPT2 ACOT12 DGAT2	7.15e-05	39	130	4	CID000161757
Drug	caffeic acid phenethyl ester	CYP1A2 CEBPE CAT EDN1 KCNT2 SND1 PREP AHR VCPIP1	7.65e-05	311	130	9	ctd:C055494
Drug	triethyl lead chloride	PREP GLUD1 GLUD2	7.87e-05	15	130	3	CID000014019
Drug	UROX	CYP1A2 CAT AHR	7.87e-05	15	130	3	CID000008799
Drug	AC1Q68ZE	ETFDH ACOT12 DGAT2 GLUD1 GLUD2	9.03e-05	79	130	5	CID000000265
Drug	apigenin	CYP1A2 RANBP1 ITGB4 PIKFYVE PARP1 AHR SPEN	9.19e-05	184	130	7	CID005280443
Drug	2-dichlorobenzene	CYP1A2 CAT GLUD1	9.65e-05	16	130	3	ctd:C004726
Drug	oleoylcarnitine	CPT2 GLUD1 GLUD2	9.65e-05	16	130	3	CID006441392
Drug	cryptotanshinone	CYP1A2 PARP1 AHR	9.65e-05	16	130	3	ctd:C037886
Drug	2,3-diaminotoluene	CYP1A2 AHR	9.67e-05	3	130	2	ctd:C100420
Drug	2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine	CYP1A2 AHR	9.67e-05	3	130	2	ctd:C522525
Drug	Suppressor Factors, Immunologic	CYP1A2 AHR	9.67e-05	3	130	2	ctd:D013491
Drug	lenthionine	GLUD1 GLUD2	9.67e-05	3	130	2	CID000067521
Drug	alyssin	CYP1A2 AHR	9.67e-05	3	130	2	ctd:C524316
Drug	2-oxohexyl isothiocyanate	CYP1A2 AHR	9.67e-05	3	130	2	ctd:C524315
Drug	mildiomycin	GLUD1 GLUD2	9.67e-05	3	130	2	CID000125665
Drug	methoxyethylmercury	GLUD1 GLUD2	9.67e-05	3	130	2	CID000115155
Drug	4-methylumbelliferyl laurate	GLUD1 GLUD2	9.67e-05	3	130	2	CID000600674
Drug	triple sulfa	MCPH1 CAT	9.67e-05	3	130	2	CID000060896
Drug	1,2,3,7,8-pentachlorodibenzofuran	CYP1A2 AHR	9.67e-05	3	130	2	ctd:C057584
Drug	methylmercuric iodide	GLUD1 GLUD2	9.67e-05	3	130	2	CID000067347
Drug	7-nitrobenzanthracene	CYP1A2 AHR	9.67e-05	3	130	2	ctd:C038954
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	CYP1A2 BAZ1B SPART PSPH KMT2A TSKS VCPIP1	1.16e-04	191	130	7	6020_DN
Drug	oxene	CYP1A2 CAT AHR	1.17e-04	17	130	3	CID000160438
Drug	3-amino-1-methyl-5H-pyrido(4,3-b)indole	CYP1A2 PARP1 AHR	1.17e-04	17	130	3	ctd:C019133
Drug	d-arabino-3-hexulose 6-phosphate	CPD GLUD1 GLUD2	1.17e-04	17	130	3	CID000193886
Drug	5-aminolevulinic acid	CYP1A2 CAT CPOX F8 AHR HBE1	1.27e-04	135	130	6	CID000000137
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A	BAZ1B SPART CPD DOCK5 TLN2 PRR14L PLCH1	1.36e-04	196	130	7	3534_DN
Drug	hydroxypyruvate	APTX PSPH GLUD1 GLUD2	1.38e-04	46	130	4	CID000000964
Drug	Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	BAZ1B PSPH ADARB1 SND1 CTNND2 CAMSAP1 VCPIP1	1.41e-04	197	130	7	2235_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; HL60; HT_HG-U133A	SOX4 AAK1 TNS2 ARG1 ADGB SLC6A6 TLN2	1.41e-04	197	130	7	3044_DN
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A	CYP1A2 WAS AAK1 SPART F8 DOCK5 PLCH1	1.41e-04	197	130	7	7037_DN
Drug	3-nitropropionic acid; Down 200; 10uM; PC3; HT_HG-U133A	BAZ1B CPT2 ADARB1 ITGB4 EDN1 KMT2A CAMSAP1	1.41e-04	197	130	7	6372_DN
Drug	carnitine	CYP1A2 MCPH1 ETFDH CAT CPT2 ACOT12 DGAT2 MRRF	1.45e-04	265	130	8	CID000000085
Drug	rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A	LAMB4 ERP44 TNS2 PSPH ADGB TLN2 AFDN	1.50e-04	199	130	7	2693_DN
Drug	Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; HL60; HG-U133A	CYP1A2 CPOX CPT2 NCAPG PDCD11 KMT2A AGTPBP1	1.50e-04	199	130	7	2032_DN
Drug	primaquine	CYP1A2 CAT CPOX F8 AHR	1.59e-04	89	130	5	CID000004908
Drug	phenazine ethosulfate	CAT GLUD1 GLUD2	1.65e-04	19	130	3	CID000082688
Drug	N-acetylglutamate	CAT ARG1 GLUD1 GLUD2	1.76e-04	49	130	4	CID000000185
Drug	porphyrin	CYP1A2 CAT CPD CPOX AHR HBE1	1.81e-04	144	130	6	CID000066868
Drug	methyl benzoquate	GLUD1 GLUD2	1.93e-04	4	130	2	CID000026383
Drug	1-chloropyrene	CYP1A2 AHR	1.93e-04	4	130	2	ctd:C040345
Drug	2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester	CYP1A2 AHR	1.93e-04	4	130	2	ctd:C520611
Drug	pentenoic acid	GLUD1 GLUD2	1.93e-04	4	130	2	CID000012299
Drug	GDMA	F8 ARG1	1.93e-04	4	130	2	CID000061059
Drug	alpha-ketoglutaramate	GLUD1 GLUD2	1.93e-04	4	130	2	CID000000048
Drug	ureidoglycine	GLUD1 GLUD2	1.93e-04	4	130	2	CID000439649
Drug	Ivin	GLUD1 GLUD2	1.93e-04	4	130	2	CID000014083
Drug	osimertinib	CAT PARP1	1.93e-04	4	130	2	ctd:C000603933
Drug	8-BDB-TADP	GLUD1 GLUD2	1.93e-04	4	130	2	CID000130791
Drug	cadina-3,9-diene	GLUD1 GLUD2	1.93e-04	4	130	2	CID000010657
Drug	AC1L9CUQ	GLUD1 GLUD2	1.93e-04	4	130	2	CID000442451
Drug	1,2,3,5,6,7-hexachloronaphthalene	CYP1A2 AHR	1.93e-04	4	130	2	ctd:C575652
Drug	3-((2,4-dimethylpyrrol-5-yl)methylidenyl)-2-indolinone	CYP1A2 AHR	1.93e-04	4	130	2	ctd:C549241
Drug	3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide	CYP1A2 AHR	1.93e-04	4	130	2	ctd:C520945
Drug	tasquinimod	CYP1A2 AHR	1.93e-04	4	130	2	ctd:C516109
Drug	1-(4-chlorophenyl)-benzo-2,5-quinone	CAT AHR	1.93e-04	4	130	2	ctd:C000597136
Drug	luxabendazole	GLUD1 GLUD2	1.93e-04	4	130	2	CID000072019
Drug	Piracetam	CAT PREP	1.93e-04	4	130	2	ctd:D010889
Drug	N-butylmaleimide	GLUD1 GLUD2	1.93e-04	4	130	2	CID000239780
Drug	alpha-methylglutamate	GLUD1 GLUD2	1.93e-04	4	130	2	CID000095440
Disease	Metabolic Diseases	DSG1 ETFDH AHR	9.14e-06	10	127	3	C0025517
Disease	coffee consumption	CYP1A2 LAMB4 BAZ1B AHR	1.07e-05	32	127	4	EFO_0004330
Disease	Hepatitis	SPARC CAT PARP1	3.41e-05	15	127	3	C0019158
Disease	ureteral obstruction (biomarker_via_orthology)	CAT EDN1 ARG1 PARP1	4.25e-05	45	127	4	DOID:5199 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	CYP1A2 SPARC RBM10 ETFDH PARP1 NCAPG CTNND2 DSEL TSKS ABCD2 DCLK1 AGTPBP1	5.32e-05	702	127	12	C0009402
Disease	Splenic Diseases	CYP1A2 AHR	5.50e-05	3	127	2	C0037997
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	5.50e-05	3	127	2	DOID:885 (biomarker_via_orthology)
Disease	Porphyria Cutanea Tarda	CYP1A2 CPOX	1.10e-04	4	127	2	C0162566
Disease	complex cortical dysplasia with other brain malformations (is_implicated_in)	CTNNA2 CAMSAP1	1.10e-04	4	127	2	DOID:0090131 (is_implicated_in)
Disease	insomnia measurement	TANC2 MYCBP2 VPS8 ADARB1 PER2 KMT2A KIF2A CTNND2 PLCH1	1.33e-04	443	127	9	EFO_0007876
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	2.73e-04	6	127	2	DOID:1825 (biomarker_via_orthology)
Disease	response to angiotensin receptor blocker	ZHX2 TNNT3 BICC1	2.90e-04	30	127	3	EFO_0010735
Disease	Asthma	CAT EDN1 ARG1 PARP1	4.02e-04	80	127	4	C0004096
Disease	dilated cardiomyopathy (is_marker_for)	RANBP1 CAT EDN1	6.35e-04	39	127	3	DOID:12930 (is_marker_for)
Disease	Silicosis	ARG1 AHR	6.49e-04	9	127	2	C0037116
Disease	Disorder of fatty acid metabolism	ETFDH CPT2	6.49e-04	9	127	2	cv:C0268634
Disease	total blood protein measurement	CABLES2 MCPH1 IQGAP2 PARP1 SND1 AFDN TMEM131 HDLBP	7.48e-04	449	127	8	EFO_0004536
Disease	carotid artery intima media thickness	MCPH1 IQGAP2 VPS8 DOCK5 PREP TLN2 CTNNA2 HBE1	7.59e-04	450	127	8	EFO_0007117
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma	IQGAP2 CTNNA2 DCLK1	7.91e-04	42	127	3	EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354
Disease	serum metabolite measurement	TANC2 CYP1A2 LAMB4 MCPH1 ETFDH CKAP5 CAT PSPH CPT2 ARG1 KCNT2 TLN2	8.02e-04	945	127	12	EFO_0005653
Disease	sweet beverage consumption measurement	CYP1A2 AHR	8.09e-04	10	127	2	EFO_0010090
Disease	membranoproliferative glomerulonephritis (biomarker_via_orthology)	SPARC EDN1	8.09e-04	10	127	2	DOID:2920 (biomarker_via_orthology)
Disease	Atrophic	CYP1A2 AHR	8.09e-04	10	127	2	C0333641
Disease	1-methylxanthine measurement	CYP1A2 AHR	9.86e-04	11	127	2	EFO_0021174
Disease	Premature Birth	CAT EDN1	9.86e-04	11	127	2	C0151526
Disease	Salivary Gland Neoplasms	SOX4 ITGB4 SPEN	1.10e-03	47	127	3	C0036095
Disease	Amelogenesis Imperfecta	ITGB4 FAM83H	1.18e-03	12	127	2	C0002452
Disease	neovascular inflammatory vitreoretinopathy (is_marker_for)	CAT EDN1	1.18e-03	12	127	2	DOID:9719 (is_marker_for)
Disease	L2 Acute Lymphoblastic Leukemia	CYP1A2 CEBPE KMT2A	1.32e-03	50	127	3	C0023453
Disease	Amino Acid Metabolism, Inherited Disorders	PSPH ARG1	1.39e-03	13	127	2	C0750905
Disease	Amino Acid Metabolism, Inborn Errors	PSPH ARG1	1.39e-03	13	127	2	C0002514
Disease	Childhood Acute Lymphoblastic Leukemia	CYP1A2 CEBPE KMT2A	1.48e-03	52	127	3	C0023452
Disease	Necrosis	SPARC CAT AHR	1.73e-03	55	127	3	C0027540
Disease	periprosthetic osteolysis, disease progression measurement	CEMIP CTNNA2	1.86e-03	15	127	2	EFO_0008336, EFO_0009761
Disease	hepatic encephalopathy (biomarker_via_orthology)	GLUD1 GLUD2	1.86e-03	15	127	2	DOID:13413 (biomarker_via_orthology)
Disease	coffee consumption, cups of coffee per day measurement	CYP1A2 AHR	2.12e-03	16	127	2	EFO_0004330, EFO_0006782
Disease	Dermatitis	DSG1 PARP1	2.12e-03	16	127	2	C0011603
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	CYP1A2 CEBPE KMT2A	2.34e-03	61	127	3	C1961102
Disease	choline measurement	SULF2 DGAT2 PLCH1 BICC1	2.45e-03	130	127	4	EFO_0010116
Disease	transient cerebral ischemia (implicated_via_orthology)	ADARB1 PARP1 KMT2A	2.68e-03	64	127	3	DOID:224 (implicated_via_orthology)
Disease	Hypertrophy	EDN1 AHR	2.69e-03	18	127	2	C0020564
Disease	type 2 diabetes mellitus (is_marker_for)	CAT F8 EDN1 PARP1	2.88e-03	136	127	4	DOID:9352 (is_marker_for)
Disease	kidney failure (biomarker_via_orthology)	EDN1 PARP1	3.00e-03	19	127	2	DOID:1074 (biomarker_via_orthology)
Disease	caffeine metabolite measurement	CYP1A2 AHR	3.00e-03	19	127	2	EFO_0007872
Disease	Cardiomyopathies, Primary	CAT EDN1 PARP1	3.32e-03	69	127	3	C0033141
Disease	Myocardial Diseases, Secondary	CAT EDN1 PARP1	3.32e-03	69	127	3	C0036529
Disease	Non-alcoholic Fatty Liver Disease	CYP1A2 CAT AHR	3.45e-03	70	127	3	C0400966
Disease	Nonalcoholic Steatohepatitis	CYP1A2 CAT AHR	3.45e-03	70	127	3	C3241937
Disease	blood urea nitrogen measurement	CYP1A2 PPFIA2 CHD9 SLF2 AHR TANC1 BICC1	3.50e-03	452	127	7	EFO_0004741
Disease	Lung Injury	CYP1A2 AHR	3.66e-03	21	127	2	C0273115
Disease	Chronic Lung Injury	CYP1A2 AHR	3.66e-03	21	127	2	C2350344
Disease	Arthrogryposis	VPS8 TNNT3	3.66e-03	21	127	2	C0003886
Disease	Splenomegaly	CYP1A2 AHR	4.01e-03	22	127	2	C0038002
Disease	Acute Lung Injury	CAT EDN1	4.01e-03	22	127	2	C0242488

Protein segments in the cluster

Peptide	Gene	Start	Entry
LHGQKKKGKDGSILP	AHR	246	P35869
KKHLEGKTPKGKERA	AFDN	356	P55196
VPALAGHKKDIGRLK	EGFL6	436	Q8IUX8
KAKVFEHIGKKTPIA	CAT	96	P04040
GPLHKGKKAVNKDSL	CEBPE	191	Q15744
PKFGKLVAEEAHRKG	ABCD2	276	Q9UBJ2
LLNKDFAKLGEGKHP	AAK1	711	Q2M2I8
GAKEKDKTGKSPVFH	ADGB	66	Q8N7X0
KHSDKPLKAKGRSKG	BAZ1B	396	Q9UIG0
KKGKDAPIKKESLGH	APTX	166	Q7Z2E3
FVAKPVGKEKIHLKP	ACOT12	111	Q8WYK0
KDPVIGKSSQRKGHK	AKAP11	376	Q9UKA4
GKSHKSPADIVKNLK	CAB39	6	Q9Y376
HAGDILKFLKKKKPE	AMZ2	151	Q86W34
KKPVSSGRKHSLGKE	CEP78	361	Q5JTW2
IGAKSKKDPHIKVSG	BICC1	96	Q9H694
HSILAKIGPKDKKFG	AGTPBP1	136	Q9UPW5
GKAAFLHVVKKGKAE	CAMSAP1	911	Q5T5Y3
PKKLFGSQLKTKDHF	CEMIP	1196	Q8WUJ3
VGISKSKGDKHSPKV	CTNND2	991	Q9UQB3
HGQPVSFLLKELKGK	ARG1	141	P05089
GGKEFLKKQKLSPDA	CPT2	451	P23786
HKETGAPSKEGKEKK	RBM10	626	P98175
GTGDVKLLKHKEKGA	RANBP1	71	P43487
YKLHSKPGKKEKERG	RAB11FIP5	146	Q9BXF6
RDITGALFKHSKKGP	CYP1A2	281	P05177
SHISKLPKGKHSVKG	PARP1	936	P09874
VGPYDILAGKHKTKK	HPF1	81	Q9NWY4
KGKHKLNKGVFGEKP	KCNH3	186	Q9ULD8
KTVKHKILVLSGKGG	NUBP1	51	P53384
HKGKVKGCKTPLQSF	ANKRD13B	296	Q86YJ7
GFKDLIKPHEELKKS	MCPH1	626	Q8NEM0
IKPHEELKKSGRGKK	MCPH1	631	Q8NEM0
LGNPKVKAHGKKVLT	HBE1	56	P02100
KPEQRSHKKGAGAKK	H1-10	166	Q92522
AGSKQHESIPGKAKK	IMUP	71	Q9GZP8
VAGKIKKHFNTGPKP	DCLK1	661	O15075
HLKKFPQGQKGKVVF	DDX58	281	O95786
KYLITAAAKAKHGKP	IDO2	366	Q6ZQW0
HLPADKKAKGKASTL	PER2	121	O15055
VLDPEGKGTIKKKFL	MYLPF	106	Q96A32
HLEFLSGEKKNKKSP	KNOP1	106	Q1ED39
GSKRKGKVHGLSKIA	MEIKIN	36	A0A087WXM9
LFKGKRAHGPALLTK	F8	991	P00451
LSRKGPKHSGKTAEK	KCNT2	1021	Q6UVM3
EGSGPTKKKAKLHAA	ADARB1	121	P78563
KGNIHLKPSFSDGLK	ITGB4	431	P16144
LGPKFKKLADISLGK	DSG1	751	Q02413
GKLAKEIAEKLGFKH	NDUFA10	71	O95299
HKKGIKLDGSHPAFL	PREP	456	P48147
KHKGTPKVGDTIRKT	FBXO43	361	Q4G163
KGKLHGKFSLIDLAG	KIF2A	446	O00139
EKKPFKGKGKTAFSH	FRG2C	36	A6NGY1
IRQFVHIKKIPGGKK	PIKFYVE	661	Q9Y2I7
HIKKIPGGKKFDSVV	PIKFYVE	666	Q9Y2I7
LKHKGSDFERLKPAK	ETFDH	486	Q16134
HGKKAGLAADKKEFK	CKAP5	501	Q14008
LIDKLLPKMKAGGHK	CHD9	1186	Q3L8U1
EGICGTAHKKKKPDV	CASP5	271	P51878
KHKGGILRKGAKLFF	C2CD2	621	Q9Y426
IHGEFDKGKKKTPKN	DOCK5	451	Q9H7D0
PSGKKKGRSKKAHVL	CTNNA2	46	P26232
FKLQHGSILGFPKAK	GLUD1	351	P00367
HGFVKDKTGKPISKA	CPD	1216	O75976
VFKKVFIHAGLKGKP	DNAH14	2051	Q0VDD8
DTPKKKKHKGGSEFT	ING5	151	Q8WYH8
PGKLKQFVFDLHSGK	ERP44	341	Q9BS26
KLGFFAHKKIPEEEK	ITGA10	1146	O75578
PLDKGNGKKHKVSHL	KMT2A	3546	Q03164
LKHPVFPSGKFLKVK	LAMB4	1231	A4D0S4
DIKGPEDKKKHLLIG	ATP5F1C	81	P36542
QEKLLKDSGVFGKPK	CCDC174	31	Q6PII3
GKSFKGHVKEKFLLV	FAM83H	221	Q6ZRV2
VKSSFHDPKLKGKPS	EDN1	186	P05305
SLVKKLFQGPGKDKA	FAM110C	121	Q1W6H9
IAKYPHKIKSGAEAK	POLB	46	P06746
HKIKSGAEAKKLPGV	POLB	51	P06746
EHLAKLFKIEGGKGK	DSEL	1056	Q8IZU8
GKVLKTKDGKLPFCA	CPOX	226	P36551
GSPRHKGLKKTHFIK	CABLES2	151	Q9BTV7
FKLQHGSILGFPKAK	GLUD2	351	P49448
LVKLFDKHKTKFGLP	DGAT2	366	Q96PD7
LHKAPKKKGIKSSIG	PPFIA2	821	O75334
IHGAFAKKGVLPLKK	PRR14L	1506	Q5THK1
ILKIPSAKGKHKAFS	OR10A5	226	Q9H207
KHCGKIKTHFLKPPG	FER1L6	751	Q2WGJ9
PDKKSKKSLIGGNHS	SLITRK4	786	Q8IW52
QPGFRKHLGLLEKKK	UTP11	21	Q9Y3A2
ALKKGSSTFPDHKVK	ATP6V1C2	281	Q8NEY4
GKAGCFSPKISHKEK	ARHGAP11A	416	Q6P4F7
LAAPGKHLAEKKVKR	SOX4	281	Q06945
KDFHKDILKPSPGKS	SLC6A6	11	P31641
KDLHLGKLALTKFPK	PTAR1	121	Q7Z6K3
KDLKHKKLPLGLTFS	HKDC1	141	Q2TB90
VLDKDGKKKHSRPTF	NKX6-2	141	Q9C056
GEEKKGKKIKTHHAP	NBPF11	846	Q86T75
AKPVKYTAAKLHEKG	IQGAP2	1476	Q13576
PVRHFATKKAKAKGK	MRRF	51	Q96E11
KHKLGRASSKFKDPP	SIPA1L2	11	Q9P2F8
AIKNGKGLHSKKEVP	SND1	486	Q7KZF4
ILKAHIFKGLSKKTG	TANC1	866	Q9C0D5
ILKAHIFKGLSKKVG	TANC2	816	Q9HCD6
HTRPKKEKSSFLFKG	MYCBP2	2996	O75592
LKRKKKLPDSFSLHG	VPS8	116	Q8N3P4
KAAEHKAKSLGEKSP	SURF6	61	O75683
KEKFIKHIALKTPGD	SLF2	371	Q8IX21
GDLKDKSFKQSHKPL	JADE1	671	Q6IE81
LLKAGGSLKKFLFHP	TMEM176B	36	Q3YBM2
QKLGLVPEKHKGFRT	B3GNT2	341	Q9NY97
HDKTKLASGKLGKGF	AATF	371	Q9NY61
PFKTKKIKTLHCEGT	NCAPG	656	Q9BPX3
SFKVLKHPDKKFRVG	PDCD11	1186	Q14690
GKELAPHVKKHGSKL	SPART	506	Q8N0X7
RGSGLSKHFKKHQPK	ZBTB11	746	O95625
TDVKGKILPKAEHFK	XAGE2	86	Q96GT9
LKDGLFHEFKKFGKV	SPEN	351	Q96T58
GGKGKVIKLLKEKFH	PSPH	156	P78330
KKGHKLHLDYIGPCK	SPARC	136	P09486
KHKLTKAASLPGKNG	TMEM131	1641	Q92545
KKISKADIGAPSGFK	WAS	231	P42768
IISDIPFGKKFKLGK	THUMPD2	371	Q9BTF0
HKKHFKKPFKGLDRS	VPS13C	156	Q709C8
HFTPAAEVKEKGKKG	PPP1R36	61	Q96LQ0
IPKKKKAVSFHGVEP	TSKS	46	Q9UJT2
HGLLKLGSGGVVKKK	VCPIP1	1001	Q96JH7
KGKILVKGKKLPYHL	PLCH1	436	Q4KWH8
KFHPGEANFKLKLIK	ZHX2	131	Q9Y6X8
KHKPGFLDLKEFLPK	TLN2	256	Q9Y4G6
KHSKKAGTPAKGKVG	TNNT3	251	P45378
PVTCGGVKGILHKKK	SP140	591	Q13342
EVKKSQHKYVIGPKG	HDLBP	301	Q00341
EDATGKLKLHKCKGP	SULF2	466	Q8IWU5
HFLIETGPKGVKIKG	TNS2	1201	Q63HR2
LFEKHGGYKTGKLKL	PPIP5K1	421	Q6PFW1
KGKSAGREKKVIHPY	TMA16	6	Q96EY4
LFGKKAKAHKAVGQP	TYK2	351	P29597